UC WAR. CALL 06/24 2ED/ DE000HD0EDX5 /
30/05/2024 8:00:12 | Diferencia0.0000 | Bid8:00:12 | Ask- | Subyacente | Precio de ejercicio | Fecha de expiración | Tipo de opción |
---|---|---|---|---|---|---|---|
0.0010EUR | 0.00% | 0.0010 Volumen de oferta: 20,000 |
- Tamaño/ Volumen/ Formato de Ask: - |
SolarEdge Technologi... | 80.00 - | 19/06/2024 | Call |
GlobeNewswire
8:35
Nxera Pharma to Receive $4.6 Million in Milestone Payments from Centessa Pharmaceuticals
GlobeNewswire
8:30
Samsung Bioepis to Present Post-hoc Analysis of Phase 3 Study for EPYSQLI™ (SB12; Eculizumab Biosimi...
GlobeNewswire
8:30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
8:30
Nxera Pharma and PrecisionLife Expand Strategic R&D Partnership into New Therapeutic Area
GlobeNewswire
8:30
Combined General Meeting of June 20, 2024 - Availability of the preparatory documents
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página